About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,580 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,580 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 6,580 trials

RecruitingAcalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell LymphomaThe goal of this clinical trial is to study the addition of Acalabrutinib to standard R-miniCHOP in older adults with DLBCL.NCT05820841·Homburg, Saarland and 16 others CompletedAllogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesCytokine-induced killer ( CIK ) cells have been shown by our lab to be cytolytic against both autologous and allogeneic acute myeloid leukemia ( AML ) cells.NCT00460694·Singapore

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

Active not recruitingCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaThis randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with…NCT02003222·Birmingham, Alabama and 543 others

CompletedStudy of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell TransplantationBackground: \- In allogeneic stem cell transplantation (SCT), stem cells are taken from a donor and given to a recipient.NCT02356159·Bethesda, Maryland and 1 other

TerminatedPilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell LymphomaThis research study is designed to test whether the results of a diffusion MRI scan performed after one cycle of chemotherapy for lymphoma can accurately predict the outcome of…NCT00645359·Ann Arbor, Michigan

RecruitingA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaStudy J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed originator study, clinical study…NCT06876662·Miami, Florida and 35 others

CompletedAlemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell LymphomasThe primary objectives of this study are to: 1. establish the safety and dose limiting toxicities of combining alemtuzumab with CHOP chemotherapy for patients with newly…NCT00453427·Vancouver, British Columbia and 4 others

RecruitingAzacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell LymphomasThis is a multicenter prospective single arm phase II study.NCT06176027·Beijing, Beijing Municipality

CompletedDZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)This study will treat patients with DLBCL whose disease comes back or is not responding to prior therapy. This study will assess the anti-tumor activity of DZD8586 as monotherapy.NCT06539195·Hefei, Anhui and 13 others

CompletedCrizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaThis phase 1/2 trial the studies side effects and best dose of crizotinib and to see how well it works in treating young patients with solid tumors or anaplastic large cell…NCT00939770·Birmingham, Alabama and 27 others

RecruitingA Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's LymphomaA Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHLNCT07439653·Fullerton, California and 5 others

UnknownTrial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeThe first Part: recruiting untreated ENKL patients with extensive stage I or limited stage II disease (only referring to patients with the invasion of Waldeyer's ring and cervical…NCT02560441·Beijing and 4 others

Active not recruitingThe "Let's Talk Tech" Tool to Support Decision Making About Technology UseThe goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties.NCT06817122·Seattle, Washington

CompletedPilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell LymphomasMajor improvements in the treatment of childhood non-lymphoblastic lymphomas have taken place in the last ten years.NCT00001237·Bethesda, Maryland

UnknownSafety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and LymphomaThis is a single arm study to evaluate the efficacy and safety of CD19 and CD22 targeted CAR-T cells therapy for patients with relapsed/refractory B Cell Leukemia and Lymphoma.NCT04648475·Chongqing, Chongqing Municipality

CompletedA Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)There has been considerable international /national interest in the GEM-P regimen for treatment of patients with relapsed/refractory lymphoma.NCT00301301·Sutton, Surrey

CompletedIT-TT as an Effective and Well-Tolerated Strategy for CNS Prop in High-Risk DLBCL: a Prospective Ph II StudyThis is a prospective, single-arm clinical study to evaluate the efficacy and safety of intrathecal thiotepa for the prevention of central nervous system (CNS) involvement in…NCT07493486·Hangzhou, Zhejiang

Not yet recruitingThe Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell LymphomaThe study on the value of PET imaging targeting granzyme B in predicting the efficacy and prognosis of T-NK cell lymphoma.NCT06863441·Shanghai, Shanghai Municipality

RecruitingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesThis research is being done to investigate the safety and effectiveness of Darzalex Faspro (daratumumab and hyaluronidase-fihj) (a monoclonal antibody that targets plasma cells…NCT06398457·Baltimore, Maryland

CompletedStudy of Unrelated Cord Blood Transplantation Using Tacrolimus and SirolimusThe purpose of this study is to measure the effectiveness of 2 drugs, tacrolimus and sirolimus, in preventing graft versus host disease (GVHD) after treatment with chemotherapy…NCT00133367·Boston, Massachusetts and 1 other

PreviousPage 6 of 329Next